Adjusted mean (SE) change from baseline | |||
---|---|---|---|
Secondary outcome | Placebo | Desvenlafaxine 10 mg/d | Desvenlafaxine 50 mg/d |
MADRS total score | –9.87 (0.63) | –11.28 (0.63) | –10.76 (0.63) |
CGI-S total score | –1.08 (0.07) | –1.23 (0.07) | –1.11 (0.07) |
HAM-D6 total score | –4.75 (0.27) | –5.49 (0.27) | –5.19 (0.27) |
SDS total score | –2.63 (0.48) | –4.09 (0.48)† | –3.78 (0.49) |
SDS Work Studies component | –0.61 (0.17) | –1.10 (0.17)† | –1.14 (0.17)† |
SDS Social Life component | –1.08 (0.18) | –1.58 (0.17) † | –1.36 (0.18) |
SDS Life/Home Responsibilities | –0.98 (0.17) | –1.43 (0.17) | –1.20 (0.17) |
WHO-5 total score | 2.96 (0.36) | 4.51 (0.35)‡ | 3.73 (0.36) |